FDA/CDC

Unusual antibiotic resistance found in more than 200 bacteria


 

FROM A CDC TELEBRIEFING


Dr. Schuchat reiterated that simply identifying the issue is only part of the equation.

“Detection is not enough on its own. When there is a fire, somebody needs to put it out. CDC supports more than 500 local staff across the country to combat antibiotic resistance wherever it emerges.”

While the report highlights the strides that have been made in combating antibiotic resistance, Paul Auwaerter, MD, president of the Infectious Diseases Society of America, released a statement highlighting the need to further fund these efforts.

“The report spells out the need to accelerate efforts to curb resistance or face an increasing burden including novel resistance mutations that threaten health,” stated Dr. Auwaerter. “The efforts detailed in the Vital Signs report were made possible through new congressional funding in 2016 to combat antibiotic resistance. We urge Congress to sustain and to grow that investment so that further progress will prepare us to meet the future challenges of antibiotic resistance from a position of strength,” he added.

A fact sheet with a brief summation of the vital signs report is available here.

Pages

Recommended Reading

Ciprofloxacin cured gyrA wild-type Neisseria gonorrhoeae infections
MDedge Internal Medicine
Thirty-one percent of multidrug-resistant infections were community acquired
MDedge Internal Medicine
Involving experts in S. aureus bacteremia treatment reduces mortality
MDedge Internal Medicine
Fecal microbiota transplants by oral capsule noninferior to colonoscopy
MDedge Internal Medicine
FDA bans 24 ingredients from OTC health care antiseptic products
MDedge Internal Medicine
Risks identified for drug-resistant bacteremia in cirrhosis
MDedge Internal Medicine
Common food additive makes C. difficile more virulent
MDedge Internal Medicine
Drug combo indicated for bacterial pneumonia
MDedge Internal Medicine
Reported penicillin allergies hike inpatient costs
MDedge Internal Medicine
FDA warns against clarithromycin use in patients with heart disease
MDedge Internal Medicine